vs
Side-by-side financial comparison of FinVolution Group (FINV) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
FinVolution Group is the larger business by last-quarter revenue ($479.7M vs $384.8M, roughly 1.2× P3 Health Partners Inc.). FinVolution Group runs the higher net margin — 21.2% vs -19.6%, a 40.8% gap on every dollar of revenue.
Volution Group plc is a manufacturer of ventilation equipment for commercial and residential customers. Based in Crawley, West Sussex, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
FINV vs PIII — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $479.7M | $384.8M |
| Net Profit | $101.7M | $-75.5M |
| Gross Margin | — | — |
| Operating Margin | 44.6% | -40.0% |
| Net Margin | 21.2% | -19.6% |
| Revenue YoY | — | 3.8% |
| Net Profit YoY | — | -28.8% |
| EPS (diluted) | — | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $384.8M | ||
| Q3 25 | — | $345.3M | ||
| Q2 25 | — | $355.8M | ||
| Q1 25 | $479.7M | $373.2M | ||
| Q4 24 | — | $370.7M | ||
| Q3 24 | — | $362.1M | ||
| Q2 24 | — | $379.2M | ||
| Q1 24 | — | $388.5M |
| Q4 25 | — | $-75.5M | ||
| Q3 25 | — | $-31.6M | ||
| Q2 25 | — | $-20.4M | ||
| Q1 25 | $101.7M | $-20.5M | ||
| Q4 24 | — | $-58.6M | ||
| Q3 24 | — | $-46.5M | ||
| Q2 24 | — | $-12.0M | ||
| Q1 24 | — | $-18.7M |
| Q4 25 | — | -40.0% | ||
| Q3 25 | — | -12.8% | ||
| Q2 25 | — | -9.6% | ||
| Q1 25 | 44.6% | -10.2% | ||
| Q4 24 | — | -37.4% | ||
| Q3 24 | — | -29.5% | ||
| Q2 24 | — | -8.3% | ||
| Q1 24 | — | -11.3% |
| Q4 25 | — | -19.6% | ||
| Q3 25 | — | -9.1% | ||
| Q2 25 | — | -5.7% | ||
| Q1 25 | 21.2% | -5.5% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -12.8% | ||
| Q2 24 | — | -3.2% | ||
| Q1 24 | — | -4.8% |
| Q4 25 | — | $-23.08 | ||
| Q3 25 | — | $-9.67 | ||
| Q2 25 | — | $-6.23 | ||
| Q1 25 | — | $-6.28 | ||
| Q4 24 | — | $-23.13 | ||
| Q3 24 | — | $-15.70 | ||
| Q2 24 | — | $-7.37 | ||
| Q1 24 | — | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $745.0M | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | — | $-155.2M |
| Total Assets | $3.4B | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $25.0M | ||
| Q3 25 | — | $37.7M | ||
| Q2 25 | — | $38.6M | ||
| Q1 25 | $745.0M | $40.1M | ||
| Q4 24 | — | $38.8M | ||
| Q3 24 | — | $63.0M | ||
| Q2 24 | — | $73.1M | ||
| Q1 24 | — | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
| Q4 25 | — | $-155.2M | ||
| Q3 25 | — | $-18.7M | ||
| Q2 25 | — | $44.5M | ||
| Q1 25 | — | $63.3M | ||
| Q4 24 | — | $75.9M | ||
| Q3 24 | — | $120.5M | ||
| Q2 24 | — | $166.8M | ||
| Q1 24 | — | $146.6M |
| Q4 25 | — | $656.6M | ||
| Q3 25 | — | $683.6M | ||
| Q2 25 | — | $731.6M | ||
| Q1 25 | $3.4B | $783.9M | ||
| Q4 24 | — | $783.4M | ||
| Q3 24 | — | $833.3M | ||
| Q2 24 | — | $892.8M | ||
| Q1 24 | — | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $72.0M | $-25.7M |
| Free Cash FlowOCF − Capex | $70.6M | — |
| FCF MarginFCF / Revenue | 14.7% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 0.71× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.7M | ||
| Q3 25 | — | $-15.4M | ||
| Q2 25 | — | $-16.6M | ||
| Q1 25 | $72.0M | $-33.5M | ||
| Q4 24 | — | $-57.2M | ||
| Q3 24 | — | $-22.6M | ||
| Q2 24 | — | $-10.2M | ||
| Q1 24 | — | $-20.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $70.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 14.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FINV
Segment breakdown not available.
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
